Livzon Pharmaceutical Group Inc. provided earnings guidance for the third quarter and nine months ending September 30, 2017. For the nine months, the company expected net profit attributable to the shareholders of the listed company in the range of RMB 4,228.7864 million - RMB 4,269.9288 million and basic earnings per share in the range of RMB 7.73 ­ RMB 7.81. For the quarter, the company expected net profit attributable to the shareholders of the listed company in the range of RMB 3,724.7839 million to RMB 3,765.9263 million and basic earnings per share in the range of RMB 6.81 ­to RMB 6.891.